纳米粒子和抗病毒疫苗
Sen Liu1,2, Meilin Hu1,3, Xiaoqing Liu1,4
1Guangzhou National Laboratory, Guangzhou International Bio-Island, Guangzhou 510005, China.
Vaccines
|January 22, 2024
概括
纳米颗粒正在彻底改变疫苗研发,为下一代抗病毒疫苗提供有前途的平台,对抗流感和冠状病毒等疾病. 这些先进的技术旨在创造更安全,更有效的预防和治疗选择.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 纳米技术在疫苗开发中的作用
背景情况:
- 病毒构成重大威胁,导致各种感染,需要强大的人类免疫反应和有效的疫苗.
- 传统疫苗在安全性和有效性方面有所不同;生物化学和生物物理学的进步推动了疫苗设计的创新.
研究的目的:
- 审查主要致病病毒,流行病和历史疫苗开发.
- 总结抗病毒疫苗和辅助剂的特征.
- 探索基于纳米粒子的下一代抗病毒疫苗的最新进展.
主要方法:
- 对致病病毒,流行病和疫苗特征的文献综述.
- 在疫苗开发中纳米粒子应用的分析,包括自组装蛋白质聚合物,病毒样颗粒,纳米载体和纳米辅助剂.
- 讨论用于粘膜和广谱疫苗的纳米粒子潜力.
主要成果:
- 详细描述了过去两个世纪的主要病毒和流行病.
- 多种抗病毒疫苗类型和辅助剂的概述.
- 探索纳米粒子在抗流感,冠状病毒,艾滋病毒和肝炎病毒疫苗中的应用.
结论:
- 纳米粒子技术为开发下一代抗病毒疫苗提供了一个有前途的平台.
- 这些平台有可能创造广泛的预防性和治疗性疫苗.
- 纳米颗粒可以促进安全有效的粘膜疫苗的开发.
更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.5K
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
相关概念视频
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
